↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns

   e.g. "Sirolimus", "アダリムマブ"

A　B　C　D　E　F　G　H　 I 　J　K　L　M　N　O　P　Q　R　S　T　U　V　W　X　Y　Z　other

91 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名（臨床試験情報から抽出）   DrugBank   KEGG DRUG *   KEGG GENES *   KEGG PATHWAY   指定難病告示番号 * 
 1   (s)-4,5-dihydro-2-[2-hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazo   -   -   -   -   1件:
284 
 2   (s)-4,5-dihydro-2-[2-hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazolecarboxylate magnesium hydroxide   Magnesium hydroxide   D00731   -   -   1件:
284 
 3   (s)-4,5-dihydro-2[hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-m   -   -   -   -   1件:
284 
 4   (s)-4,5-dihydro-2[hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazolecarboxylate magnesium hydroxide   Magnesium hydroxide   D00731   -   -   1件:
284 
 5   Abatacept   Abatacept   D03203   2件: CD80, CD86   12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis   24件:
11,
13,
19,
41,
44,
46,
49,
50,
51,
53,
55,
60,
65,
84,
93,
96,
97,
107,
164,
222,
271,
284,
285,
300 
 6   Alefacept   Alefacept   D02800   1件: CD58   2件: Cell adhesion molecules (CAMs), Epstein-Barr virus infection   6件:
37,
60,
65,
164,
284,
285 
 7   Alemtuzumab   Alemtuzumab   D02802   -   -   13件:
13,
15,
19,
20,
46,
51,
60,
63,
65,
85,
96,
164,
284 
 8   Alpha beta depletion   -   -   -   -   2件:
60,
284 
 9   Anti-thymocyte globulin   -   -   -   -   18件:
11,
13,
14,
36,
40,
41,
42,
45,
46,
49,
51,
60,
62,
65,
164,
283,
284,
285 
 10   Antithymocyte globulin   -   -   -   -   3件:
60,
65,
284 
 11   Bpx-501 t cells   -   -   -   -   4件:
65,
284,
285,
326 
 12   Busulfan   Busulfan   D00248   -   -   13件:
19,
20,
28,
36,
49,
51,
60,
65,
164,
274,
284,
285,
326 
 13   Busulfan, cyclophosphamide, atg, gcsf   Cyclophosphamide   D00287, D07760   -   -   2件:
65,
284 
 14   Busulfan, fludarabine, atg, tli   Fludarabine   D01907, D07966   1件: RRM1   5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   2件:
65,
284 
 15   Campath, fludarabine, cyclophosphamide   Cyclophosphamide   D00287, D07760   -   -   2件:
65,
284 
 16   Cd3/cd19 depleted leukocytes   -   -   -   -   1件:
284 
 17   Cd34 stem cell selection therapy   -   -   -   -   3件:
60,
65,
284 
 18   Cd45ra depleted leukocytes   -   -   -   -   1件:
284 
 19   Cyclophosphamide   Cyclophosphamide   D00287, D07760   -   -   43件:
13,
14,
16,
19,
20,
26,
28,
35,
36,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
52,
56,
60,
61,
62,
65,
66,
84,
85,
93,
96,
162,
164,
172,
222,
224,
265,
274,
283,
284,
285,
288,
326,
331 
 20   Cyclophosphamide dose level 1   Cyclophosphamide   D00287, D07760   -   -   2件:
65,
284 
 21   Cyclophosphamide dose level 2   Cyclophosphamide   D00287, D07760   -   -   2件:
65,
284 
 22   Cyclophosphamide dose level 3   Cyclophosphamide   D00287, D07760   -   -   2件:
65,
284 
 23   Cyclophosphamide dose level 4   Cyclophosphamide   D00287, D07760   -   -   2件:
65,
284 
 24   Cyclosporine   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   33件:
11,
14,
19,
20,
28,
36,
40,
41,
42,
45,
46,
49,
50,
53,
56,
58,
60,
62,
64,
65,
90,
95,
97,
162,
164,
222,
226,
228,
234,
283,
284,
285,
302 
 25   Daclizumab   Daclizumab   D03639   1件: IL2RA   11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor   7件:
13,
56,
60,
65,
97,
283,
284 
 26   Deferasirox   Deferasirox   D03669   -   -   3件:
254,
284,
286 
 27   Deferitazole   Deferitazole   D10388   -   -   1件:
284 
 28   Deferoxamine   Deferoxamine   D01186, D03670   -   -   2件:
284,
286 
 29   Desferal   Deferoxamine   D01186, D03670   -   -   2件:
284,
286 
 30   Enriched hematopoetic stem cell infusion   -   -   -   -   3件:
13,
19,
284 
 31   Exjade   Deferasirox   D03669   -   -   3件:
254,
284,
286 
 32   Fbs0701   -   -   -   -   1件:
284 
 33   Fbs0701 capsule   -   -   -   -   1件:
284 
 34   Filgrastim   Filgrastim   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   25件:
2,
6,
13,
25,
26,
28,
34,
35,
40,
41,
42,
45,
46,
49,
51,
60,
62,
65,
96,
113,
164,
283,
284,
285,
331 
 35   Fludarabine   Fludarabine   D01907, D07966   1件: RRM1   5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   17件:
13,
28,
36,
46,
49,
51,
60,
61,
62,
65,
85,
96,
164,
283,
284,
285,
326 
 36   Fludarabine monophosphate   Fludarabine   D01907, D07966   1件: RRM1   5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   4件:
49,
65,
284,
326 
 37   Fludarabine phosphate   Fludarabine   D01907, D07966   1件: RRM1   5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   11件:
28,
36,
49,
51,
60,
62,
65,
96,
283,
284,
285 
 38   G-csf   Filgrastim   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   12件:
6,
13,
16,
49,
51,
60,
65,
85,
96,
284,
285,
331 
 39   Gcsf   Filgrastim   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   3件:
36,
65,
284 
 40   Human placental derived stem cell   -   -   -   -   4件:
19,
20,
60,
284 
 41   Hydroxide   Hydroxide ion   -   -   -   4件:
46,
96,
97,
284 
 42   Hydroxyurea   Hydroxyurea   D00341   1件: RRM2   6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway   8件:
3,
13,
19,
20,
65,
85,
86,
284 
 43   Icl670   Deferasirox   D03669   -   -   2件:
284,
286 
 44   Iron   Iron   -   -   -   7件:
13,
62,
86,
96,
97,
254,
284 
 45   Iron chelating agents   Iron   -   -   -   1件:
284 
 46   L-leucine   L-leucine   D00030   -   -   1件:
284 
 47   Lenalidomide   Lenalidomide   D04687   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   7件:
16,
26,
28,
34,
49,
284,
300 
 48   Leucine   L-leucine   D00030   -   -   7件:
5,
6,
7,
127,
283,
284,
299 
 49   Magnesium   Magnesium   -   -   -   15件:
6,
11,
13,
46,
64,
93,
97,
166,
225,
235,
284,
291,
296,
297,
298 
 50   Magnesium hydroxide   Magnesium hydroxide   D00731   -   -   1件:
284 
 51   Melphalan   Melphalan   D00369   -   -   14件:
11,
13,
14,
19,
20,
28,
60,
62,
65,
96,
164,
234,
284,
285 
 52   Mesenchymal stromal cells   -   -   -   -   6件:
36,
51,
96,
97,
274,
284 
 53   Methotrexate   Methotrexate   D00142, D02115   2件: DHFR, DHFR2   4件: Antifolate resistance, Folate biosynthesis, Metabolic pathways, One carbon pool by folate   33件:
11,
13,
19,
34,
35,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
55,
56,
60,
62,
65,
84,
93,
96,
97,
162,
164,
172,
256,
271,
284,
285,
326,
331 
 54   Methylprednisolone   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   36件:
2,
13,
25,
26,
35,
38,
39,
40,
41,
42,
43,
45,
46,
49,
50,
51,
60,
63,
64,
65,
66,
83,
84,
86,
96,
97,
145,
164,
220,
222,
224,
271,
283,
284,
285,
296 
 55   Mycophenolate   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   33件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
84,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 56   Mycophenolate mofetil   Mycophenolate mofetil   D00752, D05094, D05095   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   32件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 57   Myeloablative preparative regimen   -   -   -   -   3件:
62,
65,
284 
 58   Phosphate   Phosphate ion   -   -   -   29件:
2,
3,
11,
12,
13,
28,
36,
46,
49,
51,
53,
60,
62,
65,
70,
78,
81,
83,
90,
96,
97,
164,
235,
256,
283,
284,
285,
286,
299 
 59   Prednisone   Prednisone   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   43件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
61,
63,
64,
65,
66,
81,
84,
85,
86,
95,
96,
97,
113,
162,
164,
222,
224,
228,
251,
283,
284,
285,
288,
299,
300,
331 
 60   Reduced intensity preparative regimen   -   -   -   -   3件:
62,
65,
284 
 61   Reduced toxicity ablative regimen   -   -   -   -   3件:
62,
65,
284 
 62   Rimiducid   -   -   -   -   5件:
19,
65,
284,
285,
326 
 63   Rituximab   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   42件:
11,
13,
14,
17,
35,
36,
43,
44,
45,
46,
49,
50,
51,
52,
53,
56,
60,
61,
63,
64,
65,
66,
83,
84,
85,
86,
93,
94,
96,
97,
162,
222,
223,
229,
256,
271,
283,
284,
285,
288,
300,
331 
 64   Rivogenlecleucel   -   -   -   -   4件:
19,
65,
284,
285 
 65   Sotatercept   Sotatercept   D09670   1件: ACVR2A   4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway   2件:
86,
284 
 66   Sotatercept with prednisone boost   Sotatercept   D09670   1件: ACVR2A   4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway   1件:
284 
 67   Ssp-004184 100 mg   -   -   -   -   1件:
284 
 68   Ssp-004184 100 mg capsule   -   -   -   -   1件:
284 
 69   Ssp-004184 250 mg   -   -   -   -   1件:
284 
 70   Ssp-004184 250 mg capsule   -   -   -   -   1件:
284 
 71   Ssp-004184 375 mg   -   -   -   -   1件:
284 
 72   Ssp-004184 375 mg capsule   -   -   -   -   1件:
284 
 73   Ssp-004184 50 mg   -   -   -   -   1件:
284 
 74   Ssp-004184 50 mg capsule   -   -   -   -   1件:
284 
 75   Ssp-004184 500 mg   -   -   -   -   1件:
284 
 76   Ssp-004184 500 mg capsule   -   -   -   -   1件:
284 
 77   Ssp-004184aq 100 mg   -   -   -   -   1件:
284 
 78   Ssp-004184aq 100 mg capsule   -   -   -   -   1件:
284 
 79   Ssp-004184aq 200 mg   -   -   -   -   1件:
284 
 80   Ssp-004184aq 200 mg capsule   -   -   -   -   1件:
284 
 81   Ssp-004184aq 250 mg   -   -   -   -   1件:
284 
 82   Ssp-004184aq 250 mg capsule   -   -   -   -   1件:
284 
 83   Ssp-004184aq 375 mg   -   -   -   -   1件:
284 
 84   Ssp-004184aq 375 mg capsule   -   -   -   -   1件:
284 
 85   Ssp-004184aq 50 mg   -   -   -   -   1件:
284 
 86   Ssp-004184aq 50 mg capsule   -   -   -   -   1件:
284 
 87   Tacrolimus   Tacrolimus   D00107, D08556   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   29件:
2,
11,
13,
36,
46,
49,
50,
51,
53,
60,
61,
62,
65,
66,
85,
95,
96,
97,
113,
151,
158,
164,
222,
224,
226,
228,
283,
284,
299 
 88   Thiotepa   Thiotepa   D00583   -   -   11件:
13,
19,
20,
28,
51,
60,
65,
85,
96,
164,
284 
 89   Thiotepa--escalated dose   Thiotepa   D00583   -   -   4件:
19,
20,
65,
284 
 90   Thiotepa--single daily dose   Thiotepa   D00583   -   -   4件:
19,
20,
65,
284 
 91   Trifluoperazine   Trifluoperazine   D00799, D01448, D08636   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   2件:
283,
284 

先頭へ